Logo

Abbott’s Assert-IQ Insertable Cardiac Monitor Receives the US FDA’s Clearance for Irregular Heartbeats

Share this
Abbott

Abbott’s Assert-IQ Insertable Cardiac Monitor Receives the US FDA’s Clearance for Irregular Heartbeats

Shots:

  • The company has received the US FDA clearance for Assert-IQ ICM that offers long-term monitoring and remote programming to improve connectivity to patients with irregular heartbeats
  • It also provides physicians and users two battery options: a 3yr. battery for traditional cardiac monitoring or 6yr. battery for long-term monitoring such as those undergoing therapy & are at risk of developing further arrhythmias i.e., AF
  • The system uses Bluetooth technology to remain connected to a transmitter that checks heart rhythms every 20 seconds & transmits results in real-time to the clinic’s portal. The system also offers advanced diagnostic capabilities & relevant information about cardiovascular health to patients

Ref: PRNewswire | Image: Abbott

Related News:- Abbott’s Spinal Cord Stimulation Systems Receives the US FDA’s Approval for Chronic Back Pain

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions